<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04709900</url>
  </required_header>
  <id_info>
    <org_study_id>NNF19OC0057592</org_study_id>
    <nct_id>NCT04709900</nct_id>
  </id_info>
  <brief_title>CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes</brief_title>
  <acronym>DYNAMITE</acronym>
  <official_title>DYnamic CT Stress Myocardial perfusioN, CT Fractional Flow Reserve and Coronary CT Angiography for Optimized treatMent Strategy In Patients With sTable Chest Pain syndromEs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the DYNAMITE trial (Dynamic CT stress myocardial perfusion, CT fractional flow&#xD;
      reserve (FFR-CT) and coronary CT angiography for optimized treatment strategy in patients&#xD;
      with chest pain syndromes) is to determine the ability of combined anatomical and functional&#xD;
      cardiac CT imaging to improve morbidity and mortality in patients with suspected or known&#xD;
      ischemic heart disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Trial design&#xD;
&#xD;
      The DYNAMITE trial is an investigator-initiated, randomised controlled, open-labelled trial&#xD;
      conducted in the Capital Region of Copenhagen, Denmark&#xD;
&#xD;
      The following hypothesis will be tested:&#xD;
&#xD;
        -  First primary hypothesis: A treatment strategy guided by combined dynamic CT myocardial&#xD;
           stress perfusion, FFR-CT and CT coronary angiography improves clinical outcome compared&#xD;
           with a conventional management strategy in patients with chronic chest pain syndromes&#xD;
&#xD;
        -  Second primary hypothesis: A treatment strategy guided by combined dynamic CT stress&#xD;
           myocardial perfusion, FFR-CT and CT coronary angiography results in improved symptom&#xD;
           relief compared with a conventional management strategy in patients with chronic chest&#xD;
           pain syndromes&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2031</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Cardiovascular Events</measure>
    <time_frame>3 years</time_frame>
    <description>cardiovascular death, acute myocardial infarction, stroke or hospitalization for heart failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Individual components of the primary endpoint</measure>
    <time_frame>3 years</time_frame>
    <description>cardiovascular death; acute myocardial infarction; stroke or hospitalization for heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute myocardial infarction stratified by subtype</measure>
    <time_frame>12 months</time_frame>
    <description>Subtypes of acute myocardial infarction according to Fourth Universal Definition 2018</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization due to unstable angina pectoris, bleeding, pacemaker and/or implantable/cardioverter defibrillator implantation, surgical or percutaneous heart valve treatment</measure>
    <time_frame>3 years</time_frame>
    <description>Cardiovascular hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>3 years</time_frame>
    <description>All-cause mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>10 years</time_frame>
    <description>Long-term registry based all-cause mortality at 10 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and type of diagnostic tests performed</measure>
    <time_frame>12 months</time_frame>
    <description>Cardiac CT, Exercise ECG, perfusion Positron Emission Tomography, perfusion Single-photon emission computed tomography, perfusion magnetic resonance, invasive coronary angiography, invasive fractional flow reserve, intravascular ultrasound, optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of invasive coronary test not leading to coronary revascularization</measure>
    <time_frame>12 months</time_frame>
    <description>number of invasive procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of coronary revascularization</measure>
    <time_frame>3 years</time_frame>
    <description>Coronary bypass surgery and/or percutaneous coronary intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative iodinated contrast volume</measure>
    <time_frame>12 months</time_frame>
    <description>Cardiac computed tomography, invasive coronary angiography, invasive fractional flow reserve, intravascular ultrasound, invasive optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative radiation dose</measure>
    <time_frame>12 months</time_frame>
    <description>Cardiac CT, perfusion Positron Emission Tomography, perfusion Single-photon emission computed tomography, perfusion magnetic resonance, invasive coronary angiography, invasive fractional flow reserve, intravascular ultrasound, optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major procedural complications occuring during procedures (invasive, non-invasive or coronary revascularization)</measure>
    <time_frame>12 months</time_frame>
    <description>death, cardiac arrest, cardiac arrhytmia, acute myocardial infarction, stroke, bleeding, unplanned revascularization and any complication requiring and/or prolonging hospitalizaation at least 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minor procedural complication specific to type of procedure (invasive, non-invasive or during coronary revascularization)</measure>
    <time_frame>12 months</time_frame>
    <description>Minor procedural complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients diagnosed with non-cardiac disease as likely explanation for symptoms</measure>
    <time_frame>12 months</time_frame>
    <description>non-cardiac diseases causing chest pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seattle Angina Questionaire</measure>
    <time_frame>3 months and 12 months</time_frame>
    <description>Seattle Angina Questionaire pre-randomization, 3 months and 12 months after randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life by EQ-5D-5L instrument</measure>
    <time_frame>3 months and 12 months</time_frame>
    <description>Quality of life estimated by EQ-5D-5L instrument pre-randomization, 3 months and 12 months after randomization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Chest Syndrome</condition>
  <condition>Acute Myocardial Infarction</condition>
  <condition>Heart Failure</condition>
  <condition>Stroke</condition>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CT angiography, FFR-CT and dynamic CT stress myocardial perfusion guided treatment strategy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Evaluation and treatment strategy according to contemporary clinical practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CT angiography, FFR-CT and stress CT myocardial perfusion</intervention_name>
    <description>The study intervention team consists of a specialist in Cardiac CT imaging, an invasive cardiologist, a thoracic surgeon and a cardiology nurse specialist. Treatment strategy defined by the study team based on CT findings involve referral for percutaneous coronary intervention, Coronary Artery Bypass surgery and/or initiation of optimal medical therapy, in addition to potential supplementary diagnostic procedures.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chest pain in patients with clinically suspected or confirmed ischemic heart disease&#xD;
&#xD;
          -  Clinical indication for non-acute coronary evaluation&#xD;
&#xD;
          -  Status of coronary revascularization&#xD;
&#xD;
               1. With previous coronary revascularization - All patients&#xD;
&#xD;
               2. Without previous coronary revascularization - Ageâ‰¥65 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Persistent chest pain and signs of ongoing acute myocardial ischemia requiring acute&#xD;
             coronary intervention&#xD;
&#xD;
          -  Hospitalization and discharge with the confirmed diagnosis acute coronary syndrome&#xD;
             (STEMI or NSTEMI) within the last 6 months&#xD;
&#xD;
          -  Severe valvular heart disease as primary diagnosis and/or in potential need of&#xD;
             percutaneous or surgical valve treatment&#xD;
&#xD;
          -  Known severe heart failure (LVEF less than 35%)&#xD;
&#xD;
          -  Language, cultural or mental factors preventing the patient from understanding the&#xD;
             informed consent form&#xD;
&#xD;
          -  Known atrial fibrillation&#xD;
&#xD;
          -  Known renal impairment (estimated Glomerular Filtration Rate below &lt;30 ml/min)&#xD;
&#xD;
          -  Known x-ray contrast allergy&#xD;
&#xD;
          -  Known intolerance to adenosine infusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus F Kofoed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Rigshospitalet, University of Copenhagen, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Klaus F Kofoed, MD</last_name>
    <phone>004535458569</phone>
    <email>Klaus.kofoed@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 12, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Klaus Fuglsang Kofoed</investigator_full_name>
    <investigator_title>Clinical associated Research Professor</investigator_title>
  </responsible_party>
  <keyword>Cardiac CT</keyword>
  <keyword>Chest pain</keyword>
  <keyword>Coronary artery disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Following publication of the main results of the trial, anonymized data will be made available to other researchers through the Zenodo open data repository.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Statistical Analysis Plan and study protocol a time of publication</ipd_time_frame>
    <ipd_access_criteria>Curated by principle investigator according to contemporary law</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

